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In our previous work, the existence of the precursor and mature forms of atria1 natriuretic factor (ANF) within the bovine 
chromaffin granules has been reported. To confirm the endogenous character of these peptides, we demonstrate that nico- 
tinic activation and depolarization by KC1 increase their co-secretion from cultured chromaffin cells. The increase of in- 
tracellular levels of these atrial pcptides by phorbol ester is potentiated by addition of forskolin. The release of ANF 
and their de novo synthesis within the cultured chromaffin cells emphasize the usefulness of this model in the study of 
the mechanisms of release and storage of these pcptides in the neuronal tissues. 
Atria1 natriuretic peptide; Adrenal medulla; Neuropeptide; Chromaffin system; Neurosecretory system; Phorbol ester; (Chromaffin cell) 
1. INTRODUCTION 
It is now well established that myoendocrine 
cells in the mammalian heart synthesize and secrete 
a hormone called atria1 natriuretic factor (ANF) 
which modifies renal and cardiovascular func- 
tions. ProANF, the 126-amino acid precursor, is 
the main constituent of the intracellular pool of 
atria1 ANF as well as the unique form secreted by 
cultured cardiocytes [ 1,2]. It seems that no matura- 
tion occurred within the atria1 secretory granules, 
suggesting that proANF would be processed upon 
its release to the circulating form ANF99-126 [l-3]. 
On the one hand, in vivo and in vitro studies on 
isolated perfused heart suggested that the common 
physiological stimulus for ANF secretion is atria1 
distension [4]. On the other hand, glucocorticoids 
[5] and thyroid hormone [6] induced in vivo and in 
vitro cardiac tissue mRNA accumulation, sug- 
gesting an increase of ANF synthesis. However, a 
specific secretagogue or inducer of ANF biosyn- 
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thesis for in vitro cultured cardiocytes has not yet 
been reported. 
We have recently demonstrated the co-existence 
of ANF99-‘26 and its precursor ANF’-‘26 within 
the bovine chromaffin granules, confirming the 
maturation process of atria1 peptides in the adrenal 
medulla [7,8]. We now report the modulation of 
the biosynthesis of ANF and its precursor as well 
as their secretion from cultured chromaffin cells. 
2. MATERIALS AND METHODS 
2.1. Chromaffin cell culture 
Chromaffin cells were isolated from bovine adrenal medulla 
by the method of Livett [9] and were seeded in 75 cm’ flasks 
(Miles Laboratories, Rexdale, Ont.) at a density of 2 x 10’ cells 
in F-12 medium supplemented with 10% (v/v) horse serum, 2% 
fetal calf serum and I % penicillin-streptomycin-fungizone 
(Gibco, Burlington, Ont.) for 5 days. For biosynthesis ex- 
periments, chromaffin cells were treated for the last 3 days with 
phorbol ester (12-O-tetradecanoyl phorbol-13-acetate, TPA) 
(Sigma, St. Louis, MO), forskolin (FKL) (Calbiochem, San 
Diego, CA) or both. On day 6, the monolayer was washed twice 
with Locke’s buffer consisting of (in mM): 145 NaCl, 5.6 KCl, 
I.2 MgSO+ 2.2 CaC12, 5.6 glucose, 0.01% (w/v) heat- 
inactivated BSA and 10 Hepes, pH 7.4, and cells were harvested 
in 2 M acetic acid containing 20 mM HCI, 0.1 mM EDTA and 
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0.1 mM phenylmethylsulfonyl fluoride, sonicated, and cen- 
trifuged at 30000 x g for 30 min. For secretion experiments, the 
monolayer was exposed for 15 min at 37°C to stimulating 
agents in the presence of 1 pM each of aprotinin, leupeptin, 
pepstatin A and 1OrM l,lO-phenanthroline (Sigma) and the 
secretion medium was then collected in 1% trifluoroacetic acid 
(Pierce, Rockford, IL). 
2.2. Reversed-phase chromatography 
Secretion media and cellular extracts were first applied on a 
precolumn (RP-300, 4.6 mm x 3 cm) (Brownlee Labs, Santa 
Clara) equilibrated with 15% acetonitrile (ACN) in 0.25 N 
triethylamine-formate buffer (TEAF), pH 4.0, at a flow rate of 
2 ml/min. After 4 min of washing with the same buffer, the 
pre-column was then connected to a Vydac Cls (4.6 mm x 
25 cm) (Separation Group, Hesperia, CA) via a Rheodyne 7000 
switching valve (Rheodyne, Berkeley, CA) and ANF was 
separated using a linear gradient of 15-55% ACN in 0.25 N 
TEAF, pH 4.0, for 40 min at a flow rate of I ml/min. 
2.3. AFN detection and data analysis 
Aliquots of the HPLC profile were dried under reduced 
pressure prior to estimation both by radioimmunoassay [lo] 
(RIA) using anti-human ANF antibody from Peninsula (Bel- 
mont, CA) and by radioreceptor assay [l l] (RRA) using bovine 
adrenal cortex membranes. Determination of bound 12’1- 
labeled ANF99-‘26 was used for computerized data analysis us- 
ing a four parameter logistic equation [ 121. Statistical dif- 
ferences between treatment groups were evaluated by one-way 
analysis of variance followed by a Dunnett’s t-test according to 
a bilateral null hypothesis. Results are expressed as mean * SE. 
3. RESULTS 
In order to eliminate the interferences in the 
ANF assays and to minimize peptide losses, the use 
of an on-line system with a pre-column was found 
necessary for the chromatography of the secretion 
media as well as for chromaffin cell extracts. The 
mature form AFN99-126 eluting at 26% acetonitrile 
was equally well detected by RIA and by RRA 
(fig.1). In contrast, the proANF form eluting at 
39% acetonitrile was selectively detected by RIA 
because of its low cross-reactivity in RRA. The 
characteristic elution position and differential 
detectability of the two forms of ANF unequivo- 
cally identifies them in HPLC eluates of chromaf- 
fin cell extracts. 
One of the characteristics of an endogenous 
neuropeptide is its secretion from target cells or 
tissues following appropriate stimuli. Fig.2 il- 
lustrates the co-secretion of ANF99-‘26 and its 
precursor’-126 following exposure of chromaffin 
cells to various secretagogues. Nicotine (10 PM) in- 
duced respectively a 7- and 27-fold increase over 
the basal secretory level of immunoreactive ANF 
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Fig. 1. Reversed-phase HPLC separation profile of purified 
ANF99-‘26 and its precursor l-L26 from bovine chromaffin 
granules on the bidimensional system (RP-300-Vydac CU) with 
a linear gradient of acetonitrile of 15-55% in 0.25 N 
triethylamine formate, pH 4, over a 40 min period. The ANF 
activity in the eluted fractions were determined by both 
radioreceptor assay (RRA, upper panel) and radioimmunoassay 
(RIA, lower panel). 
(ir-ANF) (from 27 k12 up to 186 f 52 fmol/2 x 
10’ cells) and of immunoreactive proANF (ir- 
proANF) (from 10 f 1 up to 269 f 40 fmol/2 x 
10’ cells). KC1 (56 mM) also produced a concomi- 
tant 7- and 34-fold enhancement of the release of 
ir-ANF (from 27 f 12 up to 180 f 53 fmol/2 x 10’ 
cells) and of ir-proANF (from 10 f 1 up to 339 f 
48 fmoV2 x 10’ cells), respectively. The cor- 
responding intracellular contents of ir-ANF and ir- 
proANF were respectively 1030 + 146 and 2058 f 
213 fmol/2 x 10’ cells (n = 7). Basal ir-ANF and 
ir-proANF secretions were 2.5 and 0.5% of their 
respective contents. Nicotine induced the release of 
16% and 14% of the intracellular contents of ir- 
ANF and ir-proANF, respectively. KCl-induced 
depolarisation released 10 and 12% of the ir-ANF 
and its precursor intracellular contents, respec- 
tively. 
Another characteristic of an endogenous neuro- 
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Fig.2. Co-secretion of ANF99-‘26 (left panel) and its 
precursor’-L26 (right panel) from cultured chromaffin cells 
stimulated by nicotine or KC1 for 15 min at 37°C. Secretion 
medium was submitted to reversed-phase HPLC prior to ANF 
activity determination by radioimmunoassay. CTL, control; 
NIC, 10 pM nicotine; KCI, 56 mM KCl; n, number of cultures. 
* p < 0.05, ** p < 0.01 compared to control by Dunnett’ t-test. 
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Fig.3. Biosynthesis of ANF99-‘26 (left panel) and its 
precursor’-iz6 (right panel) by cultured chromaffin cells upon 
exposure to phorbol ester (12-0-tetradecanoyl 
phorbol-13-acetate), forskolin or the combined treatment for 
72 h at 37°C. Intracellular acid extracts were subjected to 
reversed-phase HPLC prior to activity determination by 
radioimmunoassay. CTL, control; TPA, 0.1 pM phorbol ester; 
FKL, 1 ,uM forskolin; T+F, 0.1 ,uM phorbol ester and 1 pM 
forskolin; n, number of cultures. *p < 0.05, **p < 0.01 
compared to control by Dunnett’s t-test. 
peptide is its in situ biosynthesis by target cells or 
tissues. Fig.3 illustrates the effect of 0.1 PM TPA, 
1 PM FKL, or the combined treatment on 
chromaffin cells intracellular ANF contents. TPA 
induced a concomitant 5- and 2-fold enhancement 
of intracellular levels of ir-ANF (from 449 f 171 
up to 2371 + 544 fmol/2 x 10’ cells) and of ir- 
proANF (from 1784 + 103 up to 4013 f 
426 fmol/2 x 10’ cells), respectively. Although 
FKL did not produce a significant increase in 
either forms of ANF, the combined treatment 
(T+F) induced respectively a 4- and 5-fold 
enhancement of ir-ANF (from 449 f 171 up to 
1912 f 498 fmol/2 x 10’ cells) and of ir-proANF 
(from 1784 f 103 up to 8952 + 1337 fmol/2 x 10’ 
cells). 
4. DISCUSSION 
Immunohistochemical studies have revealed the 
presence of ANF-like material in sympathetic 
ganglia and adrenal medulla [ 131. We have further 
reported the identification by amino acid sequenc- 
ing of both proANF and its mature form within 
chromaffin granules, suggesting a possible modu- 
lation of the biosynthesis, maturation and secre- 
tion of these atria1 peptides by cultured chromaffin 
cells [7]. We provide here the first biochemical 
evidence that ANF99-126 and its precursor1-126 are 
co-secreted by chromaffin cells. This observation 
is reminiscent of previous studies on the co-release 
of enkephalin and its enkephalin-containing 
polypeptides [9,14]. Hence, in contrast to car- 
diomyocytes [ 1,2], chromaffin cells secreted both 
proANF and its mature product, suggesting that 
the maturation process might occur in chromaffin 
granules [8]. 
It has been shown that CAMP, phorbol ester and 
KCI-induced depolarization increased neuropep- 
tide synthesis in chromaffin cells [15]. CAMP and 
KC1 depolarisation induced the accumulation of 
proenkephalin messenger RNA prior to the ap- 
pearance of the enkephalins pentapeptide [ 151. We 
have shown in this report that TPA alone or in 
combination with forskolin enhanced production 
of both forms of ANF, indicative of de novo syn- 
thesis. The potentiation by forskolin of the phor- 
bol ester effect has been also observed for the 
release of ANF by perfused heart [4] and would 
suggest the convergence of CAMP and phosphati- 
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dylinositol pathways on the regulation of ANF 
biosynthesis in chromaffin cells. The results in- 
dicate that ANF behaves as an endogenous neuro- 
peptide within the adrenal gland. 
Since adrenomedullary ANF represents 7% of 
those of cardiac origin [7], the relative contribu- 
tion of medullary ANF to the circulating level is 
presumably minor. However, previous reports 
have demonstrated that atria1 peptides inhibit 
aldosterone production by a direct action on the 
adrenal cortex both in vivo [ 161 and in vitro [ 171. 
Morphological studies indicated the presence in 
mammalian adrenal of rays of chromaffin cells 
across the cortex [l&19], again compatible with a 
paracrine role of medullary ANF. Intermixing of 
cortical and medullary adrenal cells is even more 
pronounced in other species e.g. amphibians [20]. 
In summary, bovine chromaffin cells thus pro- 
vide an interesting model alternative to cultured 
cardiocytes for investigating biosynthesis, matura- 
tion and secretion of atria1 peptides. Since chro- 
maffin cells are considered as typical paraneurons 
and since most neuropeptides are also present in 
sympathetic ganglia [9], this in vitro model would 
be suitable for investigating the biosynthesis of 
ANF as well as the physiological role of the co- 
secretion of neuropeptides and catecholamines in 
the nervous system. 
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